A case of non-comatose acute hepatic failure: An immune-related adverse event due to sequential administration of nivolumab and ipilimumab

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A case of non-comatose acute hepatic failure: An immune-related adverse event due to sequential administration of nivolumab and ipilimumab

Cited by 5 publications

References 38 publications

Clinical features of immune-mediated hepatotoxicity induced by immune checkpoint inhibitors in patients with cancers

Clinical features of immune-mediated hepatotoxicity induced by immune checkpoint inhibitors in patients with cancers

Ipilimumab/methylprednisolone sodium succinate/nivolumab

Hepatotoxicity Associated with Immune Checkpoint Inhibitors in Clinical Practice: A Study Leveraging Data from the US Food and Drug Administration's Adverse Event Reporting System

Contact Info

Product

Resources

About